These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25946569)

  • 1. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Hiejima E; Kawai T; Nakase H; Tsuruyama T; Morimoto T; Yasumi T; Taga T; Kanegane H; Hori M; Ohmori K; Higuchi T; Matsuura M; Yoshino T; Ikeuchi H; Kawada K; Sakai Y; Kitazume MT; Hisamatsu T; Chiba T; Nishikomori R; Heike T
    Inflamm Bowel Dis; 2015 Jul; 21(7):1529-40. PubMed ID: 25946569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
    Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
    Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
    Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
    J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases.
    Tominaga K; Yamagiwa S; Setsu T; Kimura N; Honda H; Kamimura H; Honda Y; Takamura M; Yokoyama J; Suzuki K; Wakai T; Terai S
    Biomed Res; 2017; 38(2):111-121. PubMed ID: 28442662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.
    Ju JK; Cho YN; Park KJ; Kwak HD; Jin HM; Park SY; Kim HS; Kee SJ; Park YW
    J Innate Immun; 2020; 12(5):422-434. PubMed ID: 32535589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Hinks TS
    Inflamm Bowel Dis; 2015 Dec; 21(12):E30. PubMed ID: 26540277
    [No Abstract]   [Full Text] [Related]  

  • 11. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease.
    Baumgart DC; Thomas S; Przesdzing I; Metzke D; Bielecki C; Lehmann SM; Lehnardt S; Dörffel Y; Sturm A; Scheffold A; Schmitz J; Radbruch A
    Clin Exp Immunol; 2009 Sep; 157(3):423-36. PubMed ID: 19664152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.
    Sturm A; de Souza HS; Fiocchi C
    Curr Drug Targets; 2008 May; 9(5):381-7. PubMed ID: 18473766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis.
    Baumgart DC; Metzke D; Guckelberger O; Pascher A; Grötzinger C; Przesdzing I; Dörffel Y; Schmitz J; Thomas S
    Clin Exp Immunol; 2011 Oct; 166(1):46-54. PubMed ID: 21762123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
    Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
    Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease.
    Yasutomi Y; Chiba A; Haga K; Murayama G; Makiyama A; Kuga T; Watanabe M; Okamoto R; Nagahara A; Nagaishi T; Miyake S
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):81-93. PubMed ID: 34461283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
    Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
    Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.